IPOL 40 [D'ag'U]/.5mL
POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) · INJECTION, SUSPENSION · Sanofi Pasteur Inc.
IPOL is a injection, suspension containing poliovirus type 1 antigen (formaldehyde inactivated), poliovirus type 2 antigen (formaldehyde inactivated), and poliovirus type 3 antigen (formaldehyde inactivated) at 40 [D'ag'U]/.5mL, taken intramuscular. Manufactured by Sanofi Pasteur Inc..
Key Facts
- Brand Name
- IPOL
- Generic Name
- POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
- NDC Code (Product)
49281-860- Manufacturer
- Sanofi Pasteur Inc.
- Strength
- 40 [D'ag'U]/.5mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA103930
- Marketing Start
- 12/21/1990
Recall History
No Recall HistoryFrequently Asked Questions
What is IPOL used for?
IPOL contains POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED). It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is IPOL a controlled substance?
IPOL is not classified as a controlled substance by the DEA.
What is the generic name for IPOL?
The generic name for IPOL is POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED). There are no other listed brand versions of POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED).
What is the NDC code for IPOL 40 [D'ag'U]/.5mL?
The NDC (National Drug Code) for IPOL 40 [D'ag'U]/.5mL is 49281-860, listed by Sanofi Pasteur Inc..
Other IPOL Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)